1. Home
  2. CHCO vs PHVS Comparison

CHCO vs PHVS Comparison

Compare CHCO & PHVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHCO
  • PHVS
  • Stock Information
  • Founded
  • CHCO 1957
  • PHVS 2015
  • Country
  • CHCO United States
  • PHVS Switzerland
  • Employees
  • CHCO N/A
  • PHVS N/A
  • Industry
  • CHCO Major Banks
  • PHVS Biotechnology: Pharmaceutical Preparations
  • Sector
  • CHCO Finance
  • PHVS Health Care
  • Exchange
  • CHCO Nasdaq
  • PHVS Nasdaq
  • Market Cap
  • CHCO 1.8B
  • PHVS 1.6B
  • IPO Year
  • CHCO N/A
  • PHVS 2021
  • Fundamental
  • Price
  • CHCO $122.43
  • PHVS N/A
  • Analyst Decision
  • CHCO Hold
  • PHVS Buy
  • Analyst Count
  • CHCO 3
  • PHVS 4
  • Target Price
  • CHCO $132.33
  • PHVS $33.00
  • AVG Volume (30 Days)
  • CHCO 85.0K
  • PHVS 222.4K
  • Earning Date
  • CHCO 10-23-2025
  • PHVS 11-12-2025
  • Dividend Yield
  • CHCO 2.58%
  • PHVS N/A
  • EPS Growth
  • CHCO 6.95
  • PHVS N/A
  • EPS
  • CHCO 8.30
  • PHVS N/A
  • Revenue
  • CHCO $300,872,000.00
  • PHVS N/A
  • Revenue This Year
  • CHCO $9.69
  • PHVS N/A
  • Revenue Next Year
  • CHCO $1.71
  • PHVS N/A
  • P/E Ratio
  • CHCO $14.76
  • PHVS N/A
  • Revenue Growth
  • CHCO 4.61
  • PHVS N/A
  • 52 Week Low
  • CHCO $102.22
  • PHVS $11.51
  • 52 Week High
  • CHCO $137.28
  • PHVS $26.33
  • Technical
  • Relative Strength Index (RSI)
  • CHCO 43.84
  • PHVS 45.84
  • Support Level
  • CHCO $121.30
  • PHVS $22.07
  • Resistance Level
  • CHCO $124.78
  • PHVS $24.01
  • Average True Range (ATR)
  • CHCO 2.21
  • PHVS 1.17
  • MACD
  • CHCO -0.33
  • PHVS -0.30
  • Stochastic Oscillator
  • CHCO 15.00
  • PHVS 20.18

About CHCO City Holding Company

City Holding Co is a financial holding company. The company conducts its principal activities through its wholly-owned subsidiary, City National Bank of West Virginia (City National). Through the bank, it provides banking, trust and investment management, and other financial solutions through its network of banking offices located in the states of West Virginia, Virginia, southeastern Ohio, and Kentucky. It offers various products and services such as overdraft facilities, savings accounts, credit cards and debit cards, loans for various purposes, investment advisory, securities brokerage, insurance products, and others. The company's business activities are currently limited to one reportable business segment, which is community banking.

About PHVS Pharvaris N.V.

Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.

Share on Social Networks: